Area of research
Immunology · Oncology
Research interest
Research interests include Immune cells in cancer, Immune Cell Function and Interaction, CAR-T cell therapy research, and Cancer Immunotherapy and Biomarkers.
Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm.
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4.
The safer effector cell? Potential of CD147 CAR NK cells to tackle tumors with lower toxicity.
Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications.
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer
The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling
Author response: Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling
Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity